Abstract
Hydroxylation of meso-methyl groups with subsequent formation of reactive benzylic esters bearing a good leaving group (e.g., sulfate, phosphate, acetate, etc.) has been proposed as a possible activation pathway in the DNA binding and carcinogenicity of some methyl-substituted polycyclic aromatic hydrocarbons (Flesher, et al., 1971; Flesher, et al., 1973). The metabolic formation of such reactive esters has recently been reported by Watabe et al. (1982, 1986, 1987; Okuda, H. et al., 1986). Their studies demonstrated the formation of electrophilic and mutagenic sulfuric acid ester metabolites from 7-hydroxymethy1-12-methylbenz[a]anthracene (HMBA) and related aromatic hydrocarbons by rat liver cytosolic sulfotransferase activity (reviewed in ref. 7). Non-enzymatic interaction of these reactive esters with the amino groups of guanine and adenine residues in calf thymus DNA produced the benzylic adducts. More recently we have noted the formation of such benzylic DNA adducts in vivo in the livers of infant rats and mice treated with HMBA, 6- hydroxymethylbenzo[a]pyrene (HMBP), or their electrophilic sulfuric acid esters (Surh, Y.-J. et al., 1987, 1989). The chemically synthesized sulfuric acid ester of 1- hydroxymethylpyrene (HMP) was also found to be highly mutagenic toward Salmonella typhimurium TA98 (Watabe, T. et al., 1982) and this intrinsic mutagenicity increased dramatically in the presence of chloride ion (Henschler, R., et al. 1989). However, the biological formation of such a labile and reactive sulfuric acid ester of HMP has not been reported.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Boberg, E.W., Miller, E.C., Miller, J.A., Poland, A. and Liem, A. (1983). Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1’sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of l’-hydroxysafrole in mouse liver. Cancer Res. 43, 5163–5173.
Flesher, J.W. and Sydnor, K.L. (1971). Carcinogenicity of derivatives of 7,12dimethylbenz[a]anthracene. Cancer Res. 31, 1951–1954.
Flesher, J.W. and Sydnor, K.L. (1973). Possible role of 6-hydroxymethylbenzo[a]pyrene as a proximate carcinogen of benzo[a]pyrene and 6-methylbenzo[a]pyrene. Int. J. Cancer 11, 433–437.
Henschler, R., Seidel, A. and Glatt, H.R. (1989). Phase-II-metabolite genotoxicity of polycyclic aromatic hydrocarbons: a chloromethyl derivative as a mutagenic intermediate from a benzylic sulfate ester. Naunyn-Schmiedeberg’s Arch. Pharmacol. 339 (Suppl.), R26.
Henschler, R., Pauly, K., Godtel, U., Seidel, a., Oesch, F. and Glatt, H.R. (1989). The mutagenicity of sulfate esters in Salmonella typhimurium is strongly affected by the ions present in the exposure medium. Mutagenesis 4, 309 (GUM abstracts).
Lai, C.-C., Miller, J.A., Miller, E.C. and Liem, A. (1985). N-Sulfooxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of Nhydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J × C3H/HeJF1 (B6C3F1) mice. Carcinogenesis 6, 1037–1045.
Okuda, H., Hiratsuka, A., Nojima, H. and Watabe, T (1986). A hydroxymethyl sulfate ester as an active metabolite of the carcinogen, 5-hydroxymethylchrycene. Biochem. Pharmacol. 35, 535–538.
Okuda, H. and Watabe, T. (1989). Formation and metabolism of the active metabolite, 9-hydroxymethyl-l0-methylanthracene phosphate, in rat liver. Proc. Jpn. Cancer Assoc. 44, (abstract #158).
Okuda, H., Yoshioka, S. and Watabe, T. (1989). Sulfotransferase-mediated activation of 9-hydroxymethyl-l0-methylanthracene, a major metabolite of the carcinogen 9,10-dimethylanthracene. Mut. Res. 216, 372 (abstract #38).
Rogan, E.G., Cavalieri, E.L. Walker, B.A., Balasubramanian, R., Wislocki, P.G., Roth, R.W. and Saugier, A.K. (1986). Mutagenicity of benzylic acetates, sulfates and bromides of polycyclic aromatic hydrocarbons. Chem. -Biol. Interact. 58, 253–275.
Squires, T.G., Schmidt, W.W. and McCandlish, C.S., Jr. (1975). Zinc chloride catalysis in the reaction of thionyl halides with aliphatic alcohols. J. Org. Chem. 40, 134–136.
Surh, Y.-J., Lai, C.-C., Miller, J.A. and Miller, E.C. (1987). Hepatic DNA and RNA adduct formation from the carcinogen 7-hydroxymethyl-12methylbenz[a]anthracene and its electrophilic sulfuric acid ester metabolite in preweanling rats and mice. Biochem. Biophys. Res. Commun. 144, 576–582.
Surh, Y.-J., Liem, A., Miller, E.C. and Miller, J.A. (1989). Metabolic activation of the carcinogen 6-hydroxymethylbenzo[a]pyrene: formation of an electrophilic sulfuric acid ester and benzylic DNA adducts in rat liver in vivo and in reactions in vitro. Carcinogenesis 10, 1519–1528.
Watabe, T., Ishizuka, T., Isobe, M. and Ozawa, N. (1982). A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science 215, 403–405.
Watabe, T., Hakamata, Y., Hiratsuka, A. and Ogura, K. (1986). A 7-hydroxymethyl sulfate ester as an active metabolite of the carcinogen, 7-hydroxymethylbenz[a]anthracene. Carcinogenesis 7, 207–214.
Watabe, T., Hiratsuka, A. and Ogura, K. (1987). Sulfotransferase-mediated covalent binding of the carcinogen, 7,12-dihydroxymethylbenz[a]anthracene to calf thymus DNA and its inhibition by glutathione transferase. Carcinogenesis 8, 445–453.
Watabe, T., Ogura, K., Okuda, H. and Hiratsuka, A. (1989). Hydroxymethyl sulfate esters as reactive metabolites of the carcinogens, 7-methyl-and 7,12- dimethylbenz[a]anthracenes and 5-methylchrycene. In Xenobiotic Metabolism and Disposition ( Kato, R., Estabrook, R.W. and Cayen, M.N. eds.), pp. 393–400, Taylor and Francis, London.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Surh, YJ., Blomquist, J.C., Miller, J.A. (1991). Activation of 1-Hydroxymethylpyrene to an Electrophilic and Mutagenic Metabolite by Rat Hepatic Sulfotransferase Activity. In: Witmer, C.M., Snyder, R.R., Jollow, D.J., Kalf, G.F., Kocsis, J.J., Sipes, I.G. (eds) Biological Reactive Intermediates IV. Advances in Experimental Medicine and Biology, vol 283. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5877-0_51
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5877-0_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5879-4
Online ISBN: 978-1-4684-5877-0
eBook Packages: Springer Book Archive